p55 CDC Activators

Common p55 CDC Activators include, but are not limited to Taxol CAS 33069-62-4, Fluorouracil CAS 51-21-8, Cisplatin CAS 15663-27-1, Doxorubicin CAS 23214-92-8 and Nutlin-3 CAS 548472-68-0.

p55 CDC activators are a category of compounds or molecules that serve to enhance the activity of p55 CDC, also known as Cyclin-dependent kinase 11 (CDK11). CDK11 belongs to the cyclin-dependent kinase family of proteins, which are fundamental regulators of the cell cycle. These kinases govern the progression of cells through various stages of the cell cycle, ensuring accurate DNA replication and cell division. CDK11 holds a particularly notable role in the regulation of both the cell cycle and transcriptional processes, making it a pivotal player in cellular homeostasis and gene expression.

The activation of p55 CDC, or CDK11, typically involves intricate interactions with other proteins and regulatory molecules. These activators have the capacity to influence the kinase's activity by promoting its association with specific cyclin partners or by modulating its phosphorylation status. CDK11 stands out among CDKs due to its two isoforms, p58 and p46, generated through alternative splicing, each with distinct functions. Activation of these isoforms can lead to distinct cellular responses. Precise control of CDK11 activity is crucial for normal cell cycle progression and gene regulation. Understanding the mechanisms governing its activation can provide insights into various cellular processes, such as transcriptional regulation, RNA splicing, and DNA repair. Researchers exploring p55 CDC activators aim to unravel the complexities of its activation, its interactions with partner molecules, and the consequences of its dysregulation, opening new avenues of inquiry in the fields of cell biology and molecular genetics.